2015 has seen an unprecedented number of cannabinoid studies, with interesting and positive outcomes for human health. This post from Marijuana.com puts together the 5 most significant cannabinoid studies of this year, till date.
With just over two months to go before we ring in 2016, this has been another stealer year for cannabinoid research. One in which countless studies have provided new and compelling evidence that marijuana’s cannabinoids offer an incredibly wide spectrum of safe, non-addictive, and effectual remedies for many of today’s more perplexing health issues.
While there have been several cannabinoid related studies performed in 2015, below are my top 5 choices for the most compelling studies/news stories published so far this year.
In this September 2015 study performed by scientists at the University of South Carolina, researchers were more than pleasantly surprised when they discovered that tetrahydrocannabinol (THC) worked wonders for inhibiting organ rejection in transplant patients. Potentially planting the seed of a whole new anti-rejection therapy for patients who have recently undergone organ transplants.
This important nugget of research demonstrates, I think, why most young males are drawn towards smoking weed as a means of coping with an onslaught of rage inducing news on a daily basis. Or, as PubMed.gov dubbed it in their July 2015 report – “the role of CB2 receptors in social and aggressive behavior.”
In this July 22, 2015 study, the Journal of Bone and Mineral Research reported that marijuana’s CBD cannabinoid had yet another miracle cure in it’s bag of tricks; helping broken bones heal faster and making them harder to break in the future.
While not summarized exactly the same way, an October 2nd study from the Great White North suggested that 2 1/2 grams of cannabis a day was a perfectly sensible and safe way of managing chronic pain. According to the research published in the Journal of Pain, small daily doses of marijuana can be safely utilized as part of a pain management program; minus the fear of addiction, mood swings, or a diminished IQ.
An August 2015 update from the National Cancer Institute to their ‘Frequently Asked Questions’ page noted that “Cannabinoids Kill Cancer” by inhibiting tumor growth and restricting the necessary blood vessel development required for tumors to spread within the host.
As the 2015 harvest season begins for outdoor cultivators, who knows what kind of scientific miracles they’ll attribute tomarijuana’s myriad of beneficial cannabinoids by the end of the year?